Spots Global Cancer Trial Database for peritoneal metastasis
Every month we try and update this database with for peritoneal metastasis cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Intraperitoneal Chemotherapy Guided by the Detection of DNA in Peritoneal Lavage Fluid in Patients With Gastric Cancer | NCT05497739 | Gastric Cancer | Intraperitoneal... Adjuvant system... | 18 Years - 75 Years | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | |
| Study of Intravenous and Intraperitoneal Paclitaxel and Oral Nilotinib for Peritoneal Carcinomatosis From Colorectal, Appendiceal, Small Bowel, Gastric, Cholangiocarcinoma, Breast, Ovarian, or Other Gynecologic Primary Cancer | NCT05185947 | Gynecologic Can... Gynecologic Neo... Peritoneal Carc... Peritoneal Neop... Ovarian Cancer Ovarian Neoplas... Colorectal Canc... Colorectal Neop... Appendiceal Can... Appendiceal Neo... | Paclitaxel Nilotinib | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Intraperitoneal Chemotherapy Guided by the Detection of DNA in Peritoneal Lavage Fluid in Patients With Gastric Cancer | NCT05497739 | Gastric Cancer | Intraperitoneal... Adjuvant system... | 18 Years - 75 Years | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | |
| Detection of Aneuploidy in Cell Free DNA to Improve the Sensitivity of Diagnostic Peritoneal Lavage in Gastric Cancer | NCT06308510 | Gastric Cancer | collection addi... | 18 Years - | Erasmus Medical Center | |
| HIPEC Combined With SOX and Sintilimab in the Treatment of Advanced Gastric Cancer With Peritoneal Metastasis | NCT06213519 | Peritoneal Meta... Gastric Cancer | S-1, Oxaliplati... | 18 Years - 75 Years | Sichuan University | |
| Development of an IDEAL Framework to Standardise Cytoreductive Surgery for Colorectal Peritoneal Metastases | NCT03733184 | Colorectal Canc... Peritoneal Meta... | Cytoreduction a... | 18 Years - 90 Years | University of Manchester | |
| Efficacy and Safety of Sintilimab Combined Intraperitoneal and Intravenous Paclitaxel Plus Oral S-1 in Gastric Cancer Patients With Peritoneal Metastasis | NCT05204173 | Gastric Cancer ... Peritoneal Meta... | sintilimab, pac... | 18 Years - | Ruijin Hospital | |
| Intraperitoneal and Intravenous Paclitaxel Chemotherapy With Oral Capecitabine for Gastric Adenocarcinoma With Peritoneal Carcinomatosis | NCT04034251 | Gastric Adenoca... Gastric Cancer Esophagogastric... Peritoneal Carc... | Paclitaxel Capecitabine BardPort Titani... | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Whole Body Diffusion MRI for Non-invasive Lesion Detection and Therapy Follow-up: Study With Patients With Ovarian Cancer and Peritoneal Metastasis | NCT01242436 | Ovarian Cancer Peritoneal Meta... | intravenous con... | - | Universitaire Ziekenhuizen KU Leuven | |
| Whole Body Diffusion MRI for Non-invasive Lesion Detection and Therapy Follow-up: Study With Patients With Ovarian Cancer and Peritoneal Metastasis | NCT01242436 | Ovarian Cancer Peritoneal Meta... | intravenous con... | - | Universitaire Ziekenhuizen KU Leuven | |
| Conversion Therapy of Hyperthermic Intraperitoneal Chemotherapy Plus Chemotherapy and Chemotherapy in Stage IV Gastric Cancer | NCT05228743 | Gastric Cancer | Comparing Hyper... Paclitaxel S1 | 18 Years - 70 Years | Tianjin Medical University Cancer Institute and Hospital | |
| A Study of 5-FU Versus MTX+5-FU in Gastric Cancer With Peritoneal Metastasis | NCT00149201 | Gastric Cancer Neoplasm Metast... | 5-FU continuous... MTX + 5-FU sequ... | 20 Years - 75 Years | Japan Clinical Oncology Group | |
| A Study of 5-FU Versus MTX+5-FU in Gastric Cancer With Peritoneal Metastasis | NCT00149201 | Gastric Cancer Neoplasm Metast... | 5-FU continuous... MTX + 5-FU sequ... | 20 Years - 75 Years | Japan Clinical Oncology Group | |
| The Functional and Clinicopathological Roles and Therapeutic Implication of Connective Tissue Growth Factor in Peritoneal Metastasis of Gastric Cancer | NCT01627119 | Gastric Cancer | 25 Years - 90 Years | National Taiwan University Hospital | ||
| Intraperitoneal and Intravenous Paclitaxel Chemotherapy With Oral Capecitabine for Gastric Adenocarcinoma With Peritoneal Carcinomatosis | NCT04034251 | Gastric Adenoca... Gastric Cancer Esophagogastric... Peritoneal Carc... | Paclitaxel Capecitabine BardPort Titani... | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Histopathological Response to FOLFOXIRI + Bevacizumab in Peritoneal Metastasis From Colorectal Cancer | NCT02591667 | Colorectal Canc... Peritoneal Meta... | Upfront staging... Neoadjuvant che... Surgical re-exp... | 18 Years - | Medical University of Vienna | |
| Histopathological Response to FOLFOXIRI + Bevacizumab in Peritoneal Metastasis From Colorectal Cancer | NCT02591667 | Colorectal Canc... Peritoneal Meta... | Upfront staging... Neoadjuvant che... Surgical re-exp... | 18 Years - | Medical University of Vienna | |
| ML Models for Predicting Postoperative Peritoneal Metastasis After Hepatocellular Carcinoma Rupture | NCT06102278 | Peritoneal Meta... | Peritoneal Meta... | 18 Years - 90 Years | Tongji Hospital | |
| Development of an IDEAL Framework to Standardise Cytoreductive Surgery for Colorectal Peritoneal Metastases | NCT03733184 | Colorectal Canc... Peritoneal Meta... | Cytoreduction a... | 18 Years - 90 Years | University of Manchester | |
| Intraperitoneal Infusion of EpCAM CAR-T Cell in Advanced Gastric Cancer With Peritoneal Metastasis (WCH-GC-CART) | NCT03563326 | Neoplasm, Stoma... Metastases, Neo... Neoplasm Seedin... | CAR-T cells tar... Chemotherapy | 18 Years - 75 Years | West China Hospital | |
| Hyperthermic Intraperitoneal Treatment of rmhTNF for CRCPM: Phase II Clinical Trial | NCT05755685 | Peritoneal Meta... Colorectal Canc... | Hyperthermic in... | 18 Years - 70 Years | Second Affiliated Hospital, School of Medicine, Zhejiang University | |
| Immunotoxin in Peritoneal Carcinomatosis- ImmunoPeCa Trial | NCT02219893 | Colorectal Neop... | MOC31PE Immunot... | 18 Years - | Oslo University Hospital | |
| Apatinib Combined With Paclitaxol as Second Line Therapy for Advanced Gastric Cancer. | NCT03144843 | Gastric Cancer | Apatinib Placebos | 18 Years - 75 Years | Sun Yat-sen University | |
| Clinical Trial on HIPEC With Mitomycin C in Colon Cancer Peritoneal Metastases (GECOP-MMC) | NCT05250648 | Peritoneal Carc... Colon Cancer | complete cytore... complete cytore... | 18 Years - | Hospital Universitario de Fuenlabrada | |
| Conversion Therapy of Hyperthermic Intraperitoneal Chemotherapy Plus Chemotherapy and Chemotherapy in Stage IV Gastric Cancer | NCT05228743 | Gastric Cancer | Comparing Hyper... Paclitaxel S1 | 18 Years - 70 Years | Tianjin Medical University Cancer Institute and Hospital | |
| Hyperthermic Intraperitoneal Treatment of rmhTNF for CRCPM: Phase II Clinical Trial | NCT05755685 | Peritoneal Meta... Colorectal Canc... | Hyperthermic in... | 18 Years - 70 Years | Second Affiliated Hospital, School of Medicine, Zhejiang University | |
| Identify the Clinical Significance and Potential Implications of Peritoneal Washing Cytology (PWC) in Patients With Pancreatic Cancer | NCT01127815 | Pancreatic Canc... | 20 Years - 90 Years | National Taiwan University Hospital | ||
| The Study of Intraperitoneal Docetaxel Plus S-1 for Malignant Ascites | NCT02779608 | Stomach Neoplas... Peritoneal Meta... | intraperitoneal... oral S-1 | 20 Years - 75 Years | Fudan University | |
| The Efficacy and Safety of HIPEC Combined With PD-1 and SOX Chemotherapy for the Translational Treatment of GC or EGJC With PM | NCT06427252 | Gastric Cancer,... | HIPEC Systemic therap... | 18 Years - 75 Years | The First Affiliated Hospital with Nanjing Medical University | |
| A Study of 5-FU Versus MTX+5-FU in Gastric Cancer With Peritoneal Metastasis | NCT00149201 | Gastric Cancer Neoplasm Metast... | 5-FU continuous... MTX + 5-FU sequ... | 20 Years - 75 Years | Japan Clinical Oncology Group | |
| Detection of Peritoneal Metastasis of Gastric Cancer by Liquid Biopsy in Peripheral Blood: A Prospective Study | NCT05347524 | Cancer | Baseline blood ... | 18 Years - 74 Years | Shanghai Zhongshan Hospital | |
| Apatinib Combined With Paclitaxol as Second Line Therapy for Advanced Gastric Cancer. | NCT03144843 | Gastric Cancer | Apatinib Placebos | 18 Years - 75 Years | Sun Yat-sen University | |
| Camrelizumab Combined With Intraperitoneal Infusion of Nab-paclitaxel, Intravenous Chemotherapy and S-1 in the Treatment of Advanced Gastric Cancer With Peritoneal Metastasis：Single-arm, Prospective Clinical Study | NCT05441254 | Stage IV Gastri... | Camrelizumab; N... | 18 Years - 75 Years | Zhongshan Hospital Xiamen University | |
| Pilot Study on Intra-abdominal Photodynamic Diagnosis in Peritoneal Carcinosis | NCT02840331 | Peritoneal Carc... | St. John's Wort Photodynamic di... | 18 Years - | University Hospital Tuebingen | |
| Safety and Efficacy of Mitomycin C-based HIPEC After srHCC and PM of HCC | NCT05544253 | Hepatocellular ... Peritoneal Meta... Hyperthymic HCC | mitomycin C-bas... | 18 Years - 80 Years | West China Hospital | |
| Immunotoxin in Peritoneal Carcinomatosis- ImmunoPeCa Trial | NCT02219893 | Colorectal Neop... | MOC31PE Immunot... | 18 Years - | Oslo University Hospital | |
| Intraperitoneal Chemotherapy Guided by the Detection of DNA in Peritoneal Lavage Fluid in Patients With Gastric Cancer | NCT05497739 | Gastric Cancer | Intraperitoneal... Adjuvant system... | 18 Years - 75 Years | Cancer Institute and Hospital, Chinese Academy of Medical Sciences |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
